[1]
M. Drummond, “VIDENCE AND VALUES: REQUIREMENTS FOR PUBLIC REIMBURSEMENT OF DRUGS FOR RARE DISEASES - A CASE STUDY IN ONCOLOGY”, J Popl Ther Clin Pharmacol, vol. 16, no. 2, Dec. 2018.